Benlysta

Understanding Benlysta® 

Benlysta® (belimumab) is a biologic medication used to treat systemic lupus erythematosus (SLE) and lupus nephritis—autoimmune diseases in which the immune system mistakenly attacks healthy tissues, leading to inflammation and organ damage.

How Benlysta® Works:

• Reduces disease activity and helps manage lupus symptoms.
• Prevents lupus flares by decreasing overactive B cells.
• Protects organs, including the kidneys, in lupus nephritis.

FDA Approvals:

• 2011 – Approved for Systemic Lupus Erythematosus (SLE)
• 2020 – Approved for Lupus Nephritis

For more information, please visit the Benlysta® patient website and speak with your healthcare provider to determine if Benlysta® is the right treatment option for you.